Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma

AIM: To investigate the influence of autologous cytokine-induced killer (CIK) cells on the phenotypes of CIK effector cells, peripheral T lymphocyte subsets and dendritic cell subsets in patients with primary hepatocellular carcinoma (HCC). METHODS: Peripheral blood mononuclear cells (PBMC) were col...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Gastroenterol
Asıl Yazarlar: Shi, Ming, Zhang, Bing, Tang, Zi-Rong, Lei, Zhou-Yun, Wang, Hui-Fen, Feng, Yong-Yi, Fan, Zhen-Ping, Xu, Dong-Ping, Wang, Fu-Sheng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Inc 2004
Konular:
Liver Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4656350/
https://ncbi.nlm.nih.gov/pubmed/15069715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v10.i8.1146
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller